Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
HBV-MPL vs Engerix-B in Adults 50-70 Years
NCT00696891Phase 3Completed
- Sponsor
- GSK
- Start
- Jun 1997
- Primary completion
- May 1999
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 3
01
Overview
Phase 3, randomised trial of hepatitis b vaccine recombinant in hepatitis B (HBV) (2 arms), sponsored by GSK. Primary endpoint: Anti-HBs antibody concentrations at Month 7. Started Jun 1997; status: completed.
02
Drugs
hepatitis b vaccine recombinant
03
Conditions
hepatitis B (HBV)
Beyond the preview
Go deeper on NCT00696891.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00696891.